DR. NATALYA ROONEY OD
Prescription History 1932548708
Optometrist in Brooklyn, NY
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. NATALYA ROONEY OD, an active Optometrist specialist practicing in Brooklyn, NY. Our medical registry currently tracks 23 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 3,371 documented patient claims. Among these therapy options, the most frequently utilized medication is Restasis, which accounts for 1,544 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other NY PrescribersVs. NY Avg |
|---|---|---|---|
| RestasisCyclosporine | 1,544 | $765.29▼ below NY avg | ▲ More than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 1,544 Medicare prescriptions for Restasis, about 17 times the volume of the typical New York prescriber of this medication (93). Medicare paid an average of $765.29 per fill, versus $1,034.99 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 1,690 30-Day Fills standardized to 30-day supplies 50,700 Days of Medication total across all patients in 2023 | |||
| Latanoprost | 264 | $12.46▼ below NY avg | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 264 Medicare prescriptions for Latanoprost, about 1.8 times the volume of the typical New York prescriber of this medication (149). Medicare paid an average of $12.46 per fill, versus $20.93 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 303.8 30-Day Fills standardized to 30-day supplies 8,046 Days of Medication total across all patients in 2023 | |||
| Azelastine Hcl | 253 | $29.98▼ below NY avg | ▲ More than typical |
About Azelastine Hcl: This medication is used to relieve nasal symptoms such as runny/itching/stuffy nose, sneezing, and post-nasal drip caused by allergies or other conditions. Show more ▾ Azelastine belongs to a class of drugs known as antihistamines. It works by blocking certain natural substances called histamines that are responsible for nasal symptoms. In 2023, this provider wrote 253 Medicare prescriptions for Azelastine Hcl, about 5.3 times the volume of the typical New York prescriber of this medication (48). Medicare paid an average of $29.98 per fill, versus $34.26 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 273 30-Day Fills standardized to 30-day supplies 8,089 Days of Medication total across all patients in 2023 | |||
| ZerviateCetirizine Hcl | 213 | $266.80▼ below NY avg | ▲ More than typical |
About Zerviate: Cetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, sneezing, hives, and itching. Show more ▾ It works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Cetirizine does not prevent hives or prevent/treat a serious allergic reaction (such as anaphylaxis). If your doctor has prescribed epinephrine to treat allergic reactions, always carry your epinephrine injector with you. Do not use cetirizine in place of your epinephrine. In 2023, this provider wrote 213 Medicare prescriptions for Zerviate, about 3.7 times the volume of the typical New York prescriber of this medication (58). Medicare paid an average of $266.80 per fill, versus $364.46 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 213 30-Day Fills standardized to 30-day supplies 5,235 Days of Medication total across all patients in 2023 | |||
| XiidraLifitegrast | 189 | $838.20▼ below NY avg | ▲ More than typical |
About Xiidra: This medication is used to treat dry eye disease. In 2023, this provider wrote 189 Medicare prescriptions for Xiidra, about 3.8 times the volume of the typical New York prescriber of this medication (50). Medicare paid an average of $838.20 per fill, versus $945.82 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 211 30-Day Fills standardized to 30-day supplies 6,330 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 170 | $316.34▼ below NY avg | ▲ More than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 170 Medicare prescriptions for Lumigan, about 2.2 times the volume of the typical New York prescriber of this medication (77). Medicare paid an average of $316.34 per fill, versus $492.27 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 204.1 30-Day Fills standardized to 30-day supplies 5,606 Days of Medication total across all patients in 2023 | |||
| Olopatadine Hcl | 140 | $73.44 | ▲ More than typical |
About Olopatadine Hcl: This medication is an antihistamine used to treat itching and redness in the eyes due to allergies. Show more ▾ This medication is not recommended for the treatment of eye irritation due to wearing contact lenses. In 2023, this provider wrote 140 Medicare prescriptions for Olopatadine Hcl, about 3.2 times the volume of the typical New York prescriber of this medication (44). Medicare paid an average of $73.44 per fill, versus $43.29 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 144.2 30-Day Fills standardized to 30-day supplies 3,990 Days of Medication total across all patients in 2023 | |||
| CombiganBrimonidine Tartrate/Timolol | 76 | $355.60▼ below NY avg | ▲ More than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 76 Medicare prescriptions for Combigan, about 1.5 times the volume of the typical New York prescriber of this medication (52). Medicare paid an average of $355.60 per fill, versus $403.34 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 112.6 30-Day Fills standardized to 30-day supplies 3,280 Days of Medication total across all patients in 2023 | |||
| CequaCyclosporine | 69 | $661.61▼ below NY avg | ▲ More than typical |
About Cequa: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 69 Medicare prescriptions for Cequa, about 2.1 times the volume of the typical New York prescriber of this medication (33). Medicare paid an average of $661.61 per fill, versus $784.72 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 75 30-Day Fills standardized to 30-day supplies 2,250 Days of Medication total across all patients in 2023 | |||
| ErythromycinErythromycin Base | 68 | $13.84▼ below NY avg | ▲ More than typical |
About Erythromycin: Erythromycin is used to treat a wide variety of bacterial infections. Show more ▾ It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. In 2023, this provider wrote 68 Medicare prescriptions for Erythromycin, about 1.3 times the volume of the typical New York prescriber of this medication (54). Medicare paid an average of $13.84 per fill, versus $19.23 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 68 30-Day Fills standardized to 30-day supplies 1,924 Days of Medication total across all patients in 2023 | |||
| Cyclosporine | 58 | $238.24▼ below NY avg | ▲ More than typical |
About Cyclosporine: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 58 Medicare prescriptions for Cyclosporine, about 2.3 times the volume of the typical New York prescriber of this medication (25). Medicare paid an average of $238.24 per fill, versus $706.30 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 64 30-Day Fills standardized to 30-day supplies 1,920 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 54 | $23.05▼ below NY avg | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 54 Medicare prescriptions for Dorzolamide-Timolol, about 60% of the volume of the typical New York prescriber of this medication (90). Medicare paid an average of $23.05 per fill, versus $32.93 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 82.1 30-Day Fills standardized to 30-day supplies 2,458 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 54 | $9.51▼ below NY avg | ≈ Typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 54 Medicare prescriptions for Timolol Maleate, about 77% of the volume of the typical New York prescriber of this medication (70). Medicare paid an average of $9.51 per fill, versus $38.85 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 105.5 30-Day Fills standardized to 30-day supplies 3,146 Days of Medication total across all patients in 2023 | |||
| Alphagan PBrimonidine Tartrate | 47 | $279.50▼ below NY avg | ≈ Typical |
About Alphagan P: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 47 Medicare prescriptions for Alphagan P, about the same volume as the typical New York prescriber of this medication (49). Medicare paid an average of $279.50 per fill, versus $396.46 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 61.9 30-Day Fills standardized to 30-day supplies 1,749 Days of Medication total across all patients in 2023 | |||
| TyrvayaVarenicline Tartrate | 44 | $681.29 | ▲ More than typical |
About Tyrvaya: Varenicline is used by adults to help stop smoking. Show more ▾ To increase your chance of success, use this medication with a stop-smoking program that includes education, support, and counseling. Quitting smoking lowers your risk of heart and lung disease, as well as cancer. Varenicline works by blocking nicotine's effects in the brain that make you want to smoke. Discuss the risks and benefits of this medication, as well as other ways to quit smoking (such as nicotine replacement treatment), with your doctor. A benzazepine derivative that functions as an ALPHA4-BETA2 NICOTINIC RECEPTOR partial agonist. It is used for SMOKING CESSATION. In 2023, this provider wrote 44 Medicare prescriptions for Tyrvaya, about 2.1 times the volume of the typical New York prescriber of this medication (21). Medicare paid an average of $681.29 per fill, versus $628.86 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 44 30-Day Fills standardized to 30-day supplies 1,305 Days of Medication total across all patients in 2023 | |||
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 31 | $52.40▼ below NY avg | ≈ Typical |
About Tobramycin-Dexamethasone: This medication is used to treat or prevent eye infections. Show more ▾ This medication contains two drugs. Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. Dexamethasone belongs to a class of drugs called corticosteroids. It works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A topical preparation of tobramycin and dexamethasone that is used for treating or preventing superficial bacterial infections of the eye. In 2023, this provider wrote 31 Medicare prescriptions for Tobramycin-Dexamethasone, about 76% of the volume of the typical New York prescriber of this medication (41). Medicare paid an average of $52.40 per fill, versus $81.44 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 33.9 30-Day Fills standardized to 30-day supplies 671 Days of Medication total across all patients in 2023 | |||
| Travoprost | 16 | $170.91▼ below NY avg | ▼ Less than typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 16 Medicare prescriptions for Travoprost, about half the volume of the typical New York prescriber of this medication (35). Medicare paid an average of $170.91 per fill, versus $266.95 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 22.7 30-Day Fills standardized to 30-day supplies 650 Days of Medication total across all patients in 2023 | |||
| Restasis MultidoseCyclosporine | 15 | $701.61▼ below NY avg | ▼ Less than typical |
About Restasis Multidose: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 15 Medicare prescriptions for Restasis Multidose, about 63% of the volume of the typical New York prescriber of this medication (24). Medicare paid an average of $701.61 per fill, versus $875.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2023 | |||
| RocklatanNetarsudil Mesylat/Latanoprost | 15 | $357.35▼ below NY avg | ▼ Less than typical |
About Rocklatan: Netarsudil/latanoprost is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent vision loss or blindness. In 2023, this provider wrote 15 Medicare prescriptions for Rocklatan, about a third of the volume of the typical New York prescriber of this medication (41). Medicare paid an average of $357.35 per fill, versus $517.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 15 30-Day Fills standardized to 30-day supplies 375 Days of Medication total across all patients in 2023 | |||
| Travatan ZTravoprost | 14 | $466.72 | ▼ Less than typical |
About Travatan Z: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 14 Medicare prescriptions for Travatan Z, about 67% of the volume of the typical New York prescriber of this medication (21). Medicare paid an average of $466.72 per fill, versus $411.56 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 15.3 30-Day Fills standardized to 30-day supplies 400 Days of Medication total across all patients in 2023 | |||
| Ofloxacin | 13 | $16.64▼ below NY avg | ▼ Less than typical |
About Ofloxacin: This medication is used to treat eye infections. Show more ▾ Ofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION. In 2023, this provider wrote 13 Medicare prescriptions for Ofloxacin, about 18% of the volume of the typical New York prescriber of this medication (73). Medicare paid an average of $16.64 per fill, versus $20.90 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 13.8 30-Day Fills standardized to 30-day supplies 269 Days of Medication total across all patients in 2023 | |||
| RhopressaNetarsudil Mesylate | 13 | $340.29▼ below NY avg | ▼ Less than typical |
About Rhopressa: Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness. In 2023, this provider wrote 13 Medicare prescriptions for Rhopressa, about a quarter of the volume of the typical New York prescriber of this medication (49). Medicare paid an average of $340.29 per fill, versus $467.97 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the NY average for this medication. 13 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2023 | |||
| BepreveBepotastine Besilate | 11 | $440.10 | ▼ Less than typical |
About Bepreve: This medication is used to treat itching of the eyes due to allergies. Show more ▾ Bepotastine is an antihistamine. It works by blocking a certain natural substance (histamine) that causes allergic symptoms. Do not use this medication to treat red or irritated eyes due to wearing contact lenses. Contact your doctor for further instructions if this occurs. In 2023, this provider wrote 11 Medicare prescriptions for Bepreve, about 16% of the volume of the typical New York prescriber of this medication (67). Medicare paid an average of $440.10 per fill, versus $383.75 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average NY prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13.3 30-Day Fills standardized to 30-day supplies 375 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. NATALYA ROONEY OD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Brooklyn, NY practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among NY prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
